Automated cell type classification in intact tissues by single-cell molecular profiling

  1. Monica Nagendran
  2. Daniel P Riordan
  3. Pehr B Harbury  Is a corresponding author
  4. Tushar J Desai  Is a corresponding author
  1. Stanford University School of Medicine, United States

Abstract

A major challenge in biology is identifying distinct cell classes and mapping their interactions in vivo. Tissue-dissociative technologies enable deep single cell molecular profiling but do not provide spatial information. We developed a proximity ligation- in situ hybridization technology (PLISH) with exceptional signal strength, specificity, and sensitivity in tissue. Multiplexed data sets can be acquired using barcoded probes and rapid label-image-erase cycles, with automated calculation of single cell profiles, enabling clustering and anatomical re-mapping of cells. We apply PLISH to expression profile ~2,900 cells in intact mouse lung, which identifies and localizes known cell types, including rare ones. Unsupervised classification of the cells indicates differential expression of 'housekeeping' genes between cell types, and re-mapping of two sub-classes of Club cells highlights their segregated spatial domains in terminal airways. By enabling single cell profiling of various RNA species in situ, PLISH can impact many areas of basic and medical research.

Data availability

The following previously published data sets were used

Article and author information

Author details

  1. Monica Nagendran

    Department of Internal Medicine, Division of Pulmonary & Critical Care, Stanford University School of Medicine, Stanford, United States
    Competing interests
    Monica Nagendran, MN has filed a provisional patent for PLISH.(Application # 62/475,090).
  2. Daniel P Riordan

    Department of Biochemistry, Stanford University School of Medicine, Stanford, United States
    Competing interests
    Daniel P Riordan, DR has filed a provisional patent for PLISH. (Application # 62/475,090).
  3. Pehr B Harbury

    Department of Biochemistry, Stanford University School of Medicine, Stanford, United States
    For correspondence
    harbury@stanford.edu
    Competing interests
    Pehr B Harbury, PH has filed a provisional patent for PLISH. (Application # 62/475,090).
  4. Tushar J Desai

    Department of Internal Medicine, Division of Pulmonary & Critical Care, Stanford University School of Medicine, Stanford, United States
    For correspondence
    tdesai@stanford.edu
    Competing interests
    Tushar J Desai, TD has filed a provisional patent for PLISH. (Application # 62/475,090).
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8794-5319

Funding

National Heart, Lung, and Blood Institute (5U01HL09999507)

  • Pehr B Harbury
  • Tushar J Desai

National Heart, Lung, and Blood Institute (1R56HL1274701)

  • Tushar J Desai

Stanford University School of Medicine (BIO-X IIP-130)

  • Pehr B Harbury
  • Tushar J Desai

Stanford University School of Medicine (ChEM-H)

  • Monica Nagendran
  • Pehr B Harbury
  • Tushar J Desai

Stanford University School of Medicine (Discovery Innovation Fund Award)

  • Pehr B Harbury

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Jay Rajagopal, Harvard University, United States

Ethics

Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (#22988) of Stanford University. The protocol was approved by the Administrative Panel on Laboratory Animal Care (APLAC) of Stanford University. Every effort was made to minimize suffering.

Human subjects: Adult human lung was obtained from Stanford Healthcare with patient informed consent and consent to publish in strict accordance with protocol 18891, approved by the Institutional Review Board Administrative Panel on Human Subjects in Medical Research of Stanford University, in compliance with requirements for protection of human subjects.

Version history

  1. Received: July 19, 2017
  2. Accepted: January 9, 2018
  3. Accepted Manuscript published: January 10, 2018 (version 1)
  4. Version of Record published: February 7, 2018 (version 2)
  5. Version of Record updated: February 9, 2018 (version 3)

Copyright

© 2018, Nagendran et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 10,457
    Page views
  • 1,659
    Downloads
  • 78
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, Scopus, PubMed Central.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Monica Nagendran
  2. Daniel P Riordan
  3. Pehr B Harbury
  4. Tushar J Desai
(2018)
Automated cell type classification in intact tissues by single-cell molecular profiling
eLife 7:e30510.
https://doi.org/10.7554/eLife.30510

Share this article

https://doi.org/10.7554/eLife.30510

Further reading

    1. Cell Biology
    2. Neuroscience
    Haibin Yu, Dandan Liu ... Kai Yuan
    Research Article

    O-GlcNAcylation is a dynamic post-translational modification that diversifies the proteome. Its dysregulation is associated with neurological disorders that impair cognitive function, and yet identification of phenotype-relevant candidate substrates in a brain-region specific manner remains unfeasible. By combining an O-GlcNAc binding activity derived from Clostridium perfringens OGA (CpOGA) with TurboID proximity labeling in Drosophila, we developed an O-GlcNAcylation profiling tool that translates O-GlcNAc modification into biotin conjugation for tissue-specific candidate substrates enrichment. We mapped the O-GlcNAc interactome in major brain regions of Drosophila and found that components of the translational machinery, particularly ribosomal subunits, were abundantly O-GlcNAcylated in the mushroom body of Drosophila brain. Hypo-O-GlcNAcylation induced by ectopic expression of active CpOGA in the mushroom body decreased local translational activity, leading to olfactory learning deficits that could be rescued by dMyc overexpression-induced increase of protein synthesis. Our study provides a useful tool for future dissection of tissue-specific functions of O-GlcNAcylation in Drosophila, and suggests a possibility that O-GlcNAcylation impacts cognitive function via regulating regional translational activity in the brain.

    1. Cancer Biology
    2. Cell Biology
    Ibtisam Ibtisam, Alexei F Kisselev
    Short Report

    Rapid recovery of proteasome activity may contribute to intrinsic and acquired resistance to FDA-approved proteasome inhibitors. Previous studies have demonstrated that the expression of proteasome genes in cells treated with sub-lethal concentrations of proteasome inhibitors is upregulated by the transcription factor Nrf1 (NFE2L1), which is activated by a DDI2 protease. Here, we demonstrate that the recovery of proteasome activity is DDI2-independent and occurs before transcription of proteasomal genes is upregulated but requires protein translation. Thus, mammalian cells possess an additional DDI2 and transcription-independent pathway for the rapid recovery of proteasome activity after proteasome inhibition.